Latest News about BNTX
Recent news which mentions BNTX
7 Blue-Chip Stocks That Are Too Cheap to Ignore
October 09, 2022
From InvestorPlace
Pfizer's Partner BioNTech Signs Research Pact With Australia
October 07, 2022
From Benzinga
From Motley Fool
1 in 5 of Americans don’t know about new omicron-targeting COVID boosters, survey finds
September 30, 2022
From MarketWatch
Canada to scrap mask mandate on planes, joining Japan, Hong Kong and U.A.E. in lifting COVID restrictions
September 27, 2022
From MarketWatch
As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster
September 27, 2022
From Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
September 27, 2022
From InvestorPlace
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
September 26, 2022
From MarketWatch
iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26
September 26, 2022
From Benzinga
Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years
September 26, 2022
From Benzinga
Pfizer CEO Contracts COVID-19 Infection For Second Time
September 26, 2022
From Benzinga
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges
September 26, 2022
From Benzinga
Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna
September 26, 2022
From Benzinga
Health official says updated COVID-19 boosters likely to be available in weeks for elementary school-age children
September 22, 2022
From MarketWatch
Why Is Novavax (NVAX) Stock Falling Today?
September 22, 2022
From InvestorPlace
From MarketWatch
Nikola, Super Micro Computer And Other Big Losers From Monday
September 20, 2022
From Benzinga
Vaccine Stocks: Down but Not Out?
September 19, 2022
From Motley Fool
Why Moderna Stock Dropped Today
September 19, 2022
From Motley Fool
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
September 19, 2022
From InvestorPlace
Health experts dismayed by President Biden’s view that the pandemic is over: ‘Hell no — not even close’
September 19, 2022
From MarketWatch
Why BioNTech, Moderna And Novavax Shares Are Diving
September 19, 2022
From Benzinga
Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine
September 14, 2022
From Benzinga
U.S. known COVID cases hold at lowest level since May, but infections are rising again in New York
September 13, 2022
From MarketWatch
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
From Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
From Benzinga
Why Novavax Stock Sank to a New 52-Week Low Today
September 06, 2022
From Motley Fool
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
From Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.